SHIRLEY YEE: Open Payments
NPI 1891461950 · PARMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,971 in 32 payments from 13 companies in 2025. Trend: 2023 $1,299 · 2024 $2,163 · 2025 $2,971
Food & beverage: $2,791Education: $180
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $508 |
| Janssen Biotech, Inc. | 5 | $366 |
| Regeneron Healthcare Solutions, Inc. | 4 | $361 |
| Novartis Pharmaceuticals Corporation | 3 | $317 |
| GENZYME CORPORATION | 4 | $300 |
| UCB, Inc. | 3 | $265 |
| LEO Pharma Inc. | 2 | $242 |
| Galderma Laboratories, L.P. | 1 | $147 |
| E.R. Squibb & Sons, L.L.C. | 1 | $114 |
| Arcutis Biotherapeutics, Inc. | 1 | $94 |
Products named: TREMFYA, DUPIXENT, Bimzelx, COSENTYX, ILUMYA, NEMLUVIO, Winlevi, ADBRY.
Industry payments across OH — which companies pay providers there.
